LEO, MARENZA
 Distribuzione geografica
Continente #
NA - Nord America 2.182
EU - Europa 865
AS - Asia 275
AF - Africa 60
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.395
Nazione #
US - Stati Uniti d'America 2.138
SE - Svezia 282
IT - Italia 182
CN - Cina 143
BG - Bulgaria 92
DE - Germania 88
GB - Regno Unito 69
SG - Singapore 53
AT - Austria 42
CA - Canada 42
FR - Francia 41
CI - Costa d'Avorio 38
VN - Vietnam 30
FI - Finlandia 20
SN - Senegal 20
IN - India 18
UA - Ucraina 16
TR - Turchia 15
BE - Belgio 11
RU - Federazione Russa 11
HK - Hong Kong 10
BR - Brasile 5
NL - Olanda 4
AU - Australia 3
EU - Europa 3
SA - Arabia Saudita 3
CH - Svizzera 2
PA - Panama 2
RO - Romania 2
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
JP - Giappone 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.395
Città #
Fairfield 288
Woodbridge 286
Houston 263
Ann Arbor 234
Chandler 158
Ashburn 138
Seattle 132
Wilmington 103
Sofia 92
Cambridge 85
Serra 66
New York 56
Beijing 52
Vienna 41
Abidjan 38
Ottawa 37
Princeton 37
Boardman 32
London 32
Lawrence 31
Medford 29
Bremen 26
Nanjing 24
Des Moines 23
Lancaster 23
Florence 22
Singapore 21
Dakar 20
Dong Ket 18
Dearborn 15
Marseille 15
Ogden 15
Frankfurt am Main 13
Brussels 11
Nanchang 10
San Diego 10
Falls Church 9
Jacksonville 9
Pisa 9
Hebei 8
Hong Kong 8
Izmir 8
Chicago 7
Kunming 6
Rome 6
Milan 5
Aosta 4
Changsha 4
Jüchen 4
Kent 4
Munich 4
Ossé 4
San Francisco 4
Tianjin 4
Toronto 4
Boulder 3
Guangzhou 3
Hangzhou 3
Jeddah 3
Jiaxing 3
Jinan 3
Manchester 3
Ningbo 3
Pesqueira 3
Redwood City 3
Vicopisano 3
Washington 3
Abano Terme 2
Ankara 2
Bucharest 2
Canberra 2
Chengdu 2
Da Nang 2
Düsseldorf 2
Egg 2
Englewood 2
Gurgaon 2
Hefei 2
Hyderabad 2
Kocaeli 2
Los Angeles 2
New Delhi 2
Northbrook 2
Panama City 2
Phoenix 2
Queens 2
Senigallia 2
Vertemate con Minoprio 2
Ambato 1
Auburn Hills 1
Central District 1
Council Bluffs 1
Dallas 1
Diss 1
Dublin 1
Fuzhou 1
Grafing 1
Harran 1
Helsinki 1
Highland 1
Totale 2.697
Nome #
Natural history of graves’ orbitopathy after treatment 168
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 158
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 151
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 149
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 141
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 138
null 121
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 117
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 113
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 113
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 111
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 111
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 109
Thyroid volume and severity of graves' orbitopathy 107
Treatment options for Graves' orbitopathy. 102
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 101
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 99
null 97
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 97
null 93
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 93
null 91
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 89
null 88
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 86
Oxidative stress in graves' disease. 79
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 75
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 75
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 68
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 66
null 65
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 58
Selenium in Graves Hyperthyroidism and Orbitopathy 55
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 35
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 29
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 23
Total thyroid ablation in Graves' orbitopathy 9
Totale 3.480
Categoria #
all - tutte 9.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020635 0 0 80 51 86 86 80 66 72 41 56 17
2020/2021286 14 19 19 30 30 10 19 29 26 31 20 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023613 64 119 54 51 46 67 6 48 118 0 37 3
2023/2024269 13 20 31 5 30 71 7 20 4 3 37 28
2024/202541 7 34 0 0 0 0 0 0 0 0 0 0
Totale 3.480